ClinicalTrials.gg
Status unknownNCT02977806Updated Apr 2, 2019

Iron Long-Term Labelling Study Malawi

An observational study in Iron Absorption, sponsored by Prof. Michael B. Zimmermann. Status unknown at 1 site in Malawi. Open to participants aged 3 Years to 10 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-04-02.

Sponsored by Prof. Michael B. Zimmermann · Observational

The sponsor has not verified this record recently (last verified Apr 2019), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
48
Ages
3 Years to 10 Years
Sex
All
01

Study summary

Conventional indirect indicators of iron status, using serum and red blood cell biomarkers, are confounded by inflammation from common infections in sub-Saharan Africa, a region with a high prevalence of iron deficiency, making the assessment of iron balance and efficiency of iron intervention difficult. A new method allowing accurate measurement of long-term oral iron absorption and allowing the estimation of iron requirements is highly needed. Such a novel method to quantify iron absorption and requirements using isotope dilution measurements in children should be validated in the present prospective observational study by following-up a group of 49 children given a stable iron isotope in an earlier trial. We will request seven blood samples within 2 years (sampling every four months) from the participants which will allow us to measure isotopic dilution for estimating total oral iron absorption over these 24 months.

02

Conditions studied

  • Iron Absorption
03

In context

Lead sponsor

Prof. Michael B. Zimmermann is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Malawian children who ingested stable iron isotopes in the frame of a former iron absorption study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Have participated in the original absorption study and the two follow-up samplings
  • Signed written from the guardian to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Long-term medication
  • Any severe metabolic, gastrointestinal kidney or chronic disease such as diabetes, hepatitis, hypertension, cancer or cardiovascular diseases (according to the guardian's statement or med-ical examination (health booklet))
  • Blood losses (surgery, accident) or blood transfusion during the past 4 months before study start.
  • Residence too far away (> 2 hours by motorbike) from study location (Zomba)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
48 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. iron isotope composition in blood

    the iron isotope ratio (tracer/tracee ratio) in blood should be analyzed with ICPMS every 120 days

    Time frame: 2 years

07

Study locations

1 site
  • College of Medicine
    Blantyre, 03, Malawi
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02977806
Lead sponsor
Prof. Michael B. Zimmermann
Responsible party
Prof. Michael B. Zimmermann (Professor, Swiss Federal Institute of Technology) — Sponsor-investigator
First posted
Nov 30, 2016
Start date
Mar 27, 2017
Primary completion
Mar 15, 2019
Completion
Dec 31, 2019 (estimated)
Last update
Apr 2, 2019

Study contacts

Michael Zimmermann, Prof.
principal investigator · Human Nutrition Laboratory, ETH Zürich

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion